Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-10

Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update concerns hepatic arterial infusion chemotherapy for hepatocellular carcinoma after surgical resection. It involves Phase 2 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatic arterial infusion chemotherapy (HAIC) (hepatic arterial infusion chemotherapy)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN